Insulin-induced vascular redox dysregulation in human atherosclerosis is ameliorated by dipeptidyl peptidase 4 inhibition.

MLA

Akoumianakis, Ioannis, et al. “Insulin-Induced Vascular Redox Dysregulation in Human Atherosclerosis Is Ameliorated by Dipeptidyl Peptidase 4 Inhibition.” Science Translational Medicine, vol. 12, no. 541, Apr. 2020. EBSCOhost, https://doi.org/10.1126/scitranslmed.aav8824.

APA

Akoumianakis, I., Badi, I., Douglas, G., Chuaiphichai, S., Herdman, L., Akawi, N., Margaritis, M., Antonopoulos, A. S., Oikonomou, E. K., Psarros, C., Galiatsatos, N., Tousoulis, D., Kardos, A., Sayeed, R., Krasopoulos, G., Petrou, M., Schwahn, U., Wohlfart, P., Tennagels, N., … Antoniades, C. (2020). Insulin-induced vascular redox dysregulation in human atherosclerosis is ameliorated by dipeptidyl peptidase 4 inhibition. Science Translational Medicine, 12(541). https://doi.org/10.1126/scitranslmed.aav8824

Chicago

Akoumianakis, Ioannis, Ileana Badi, Gillian Douglas, Surawee Chuaiphichai, Laura Herdman, Nadia Akawi, Marios Margaritis, et al. 2020. “Insulin-Induced Vascular Redox Dysregulation in Human Atherosclerosis Is Ameliorated by Dipeptidyl Peptidase 4 Inhibition.” Science Translational Medicine 12 (541). doi:10.1126/scitranslmed.aav8824.